SCHEMBL2178063

SCHEMBL2178063

Cc1cnc(O)c(N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7156845 0.77
SCHEMBL12648083 0.77
SCHEMBL30716708 0.77
SCHEMBL32680311 0.75
SCHEMBL259696 0.75
SCHEMBL30828998 0.75
SCHEMBL9122534 0.75
SCHEMBL28469850 0.73
SCHEMBL24732261 0.71
SCHEMBL31214264 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12558357-B2 Tetrahydroquinazoline derivatives as selective cytotoxic agents MERCK SHARP & DOHME LLC (US) 2026-02-24 US disclosed
EP-4204413-B1 DIHYDROQUINAZOLIN-2-ONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS USEFUL IN THE TREATMENT OF HIV MERCK SHARP & DOHME LLC (US) 2024-09-25 EP disclosed
US-20230357204-A1 TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS MERCK SHARP & DOHME LLC (US) 2023-11-09 US disclosed
CN-116745269-A Dihydroquinazolin-2-one derivatives as selective cytotoxic agents for the treatment of HIV 默沙东有限责任公司 2023-09-12 CN disclosed
EP-4204413-A1 DIHYDROQUINAZOLIN-2-ONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS USEFUL IN THE TREATMENT OF HIV Merck Sharp & Dohme LLC (US) 2023-07-05 EP disclosed
US-11648250-B2 Tetrahydroquinazoline derivatives as selective cytotoxic agents MERCK SHARP & DOHME LLC (US) 2023-05-16 US disclosed
US-20220062284-A1 TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS MERCK SHARP & DOHME CORP. (US) 2022-03-03 US disclosed
WO-2022046844-A1 DIHYDROQUINAZOLIN-2-ONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS USEFUL IN THE TREATMENT OF HIV MERCK SHARP & DOHME CORP. (US) 2022-03-03 WO disclosed
CN-101835780-B Imidazo [1,2-a ] pyrazine compounds for the treatment of viral infections such as hepatitis BIOFOCUS DPI LTD 2013-09-18 CN disclosed
EP-2567960-A2 Imidazo[1,2-a]pyrazine compounds for treatment of viral infections such as hepatitis Biofocus DPI Limited (GB) 2013-03-13 EP disclosed
US-8362018-B2 Substituted imidazo[1,2-a]pyrazine compounds useful for the treatment of viral infections BIOFOCUS DPI, LTD. (GB) 2013-01-29 US disclosed
US-8362018-B2 Substituted imidazo[1,2-a]pyrazine compounds useful for the treatment of viral infections BIOFOCUS DPI, LTD. (GB) 2013-01-29 US disclosed
US-8362018-B2 Substituted imidazo[1,2-a]pyrazine compounds useful for the treatment of viral infections BIOFOCUS DPI, LTD. (GB) 2013-01-29 US disclosed
US-20110166147-A1 IMIDAZOPYRAZINE COMPOUNDS BIOFOCUS DPI, LTD. (GB) 2011-07-07 US disclosed
US-20110166147-A1 IMIDAZOPYRAZINE COMPOUNDS BIOFOCUS DPI, LTD. (GB) 2011-07-07 US disclosed
US-20110166147-A1 IMIDAZOPYRAZINE COMPOUNDS BIOFOCUS DPI, LTD. (GB) 2011-07-07 US disclosed
CN-101835780-A Imidazo [1,2-a ] pyrazine compounds for the treatment of viral infections such as hepatitis BIOFOCUS DPI LTD 2010-09-15 CN disclosed
EP-2193131-A2 IMIDAZO[1,2-A]PYRAZINE COMPOUNDS FOR TREATMENT OF VIRAL INFECTIONS SUCH AS HEPATITIS Biofocus DPI Limited (GB) 2010-06-09 EP disclosed
WO-2009024585-A2 IMIDAZO [1,2-A] PYRAZINE COMPOUNDS FOR TREATMENT OF VIRAL INFECTIONS SUCH AS HEPATITIS BIOFOCUS DPI LIMITED (GB) 2009-02-26 WO disclosed
WO-2009024585-A2 IMIDAZO [1,2-A] PYRAZINE COMPOUNDS FOR TREATMENT OF VIRAL INFECTIONS SUCH AS HEPATITIS BIOFOCUS DPI LIMITED (GB) 2009-02-26 WO disclosed